Medicare Enrolled
Dr. Antonio Moran, M.D.
Medical Oncology · Brunswick, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Moran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Moran
Dr. Antonio Moran is a medical oncology specialist in Brunswick, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Moran performed 55,585 Medicare services across 2,939 unique beneficiaries.
Between the years covered by Open Payments, Dr. Moran received a total of $24,049 from 87 pharmaceutical and/or device companies across 954 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Moran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in GA
$24,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗55,585
Medicare services
Top 16% in GA for medical oncology
2,939
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,779 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
13,260 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 10,080 | $18 | $64 |
| Anti-nausea injection (aprepitant) | 9,230 | $1 | $6 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
9,100 | $6 | $25 |
| Iron infusion (Monoferric) | 3,400 | $16 | $74 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,762 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,670 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,060 | $1 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
798 | $62 | $277 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
513 | $10 | $67 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
471 | $89 | $390 |
| Anti-nausea injection (ondansetron/Zofran) | 432 | $0 | $3 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
412 | $8 | $9 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
394 | $20 | $103 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
363 | $90 | $421 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
272 | $10 | $39 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
231 | $11 | $66 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
174 | $42 | $208 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
164 | $72 | $210 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
145 | $1 | $4 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
111 | $9 | $28 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
99 | $13 | $41 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
98 | $44 | $205 |
| Iron level test | 95 | $6 | $20 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
93 | $24 | $135 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $118 | $509 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
82 | $50 | $234 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
80 | $14 | $65 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
75 | $20 | $164 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
67 | $3 | $11 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
65 | $12 | $39 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
65 | $17 | $83 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
56 | $17 | $71 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
51 | $0 | $3 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
50 | $3 | $13 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
49 | $59 | $313 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
42 | $38 | $180 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
40 | $16 | $62 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
30 | $9 | $27 |
| Nephelometry test A laboratory test that uses light scattering to measure the concentration of specific substances in a sample. |
28 | $13 | $41 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 27 | $20 | $63 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
26 | $6 | $19 |
| New patient office visit, complex (60-74 min) | 26 | $160 | $673 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $132 | $595 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $122 | $550 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
20 | $1 | $6 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
19 | $7 | $21 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
19 | $22 | $121 |
| PSA test (prostate cancer screening) | 18 | $18 | $56 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
18 | $9 | $28 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
14 | $25 | $78 |
| Injection, lorazepam, 2 mg | 14 | $1 | $3 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
13 | $16 | $49 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
13 | $15 | $46 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
13 | $11 | $33 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
13 | $22 | $68 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.0% high complexity
59.1% medium
8.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,049
Total received (2018-2024)
Avg $3,436/year across 7 years
Top 20% in GA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
954
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,159 (75.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,057 (21.0%)
Other
Charitable contributions, space rental, and other categories
$820 (3.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,909
2023
$4,417
2022
$4,480
2021
$1,466
2020
$621
2019
$2,875
2018
$5,281
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$542
AstraZeneca Pharmaceuticals LP
$282
Incyte Corporation
$262
Janssen Biotech, Inc.
$262
Novartis Pharmaceuticals Corporation
$245
E.R. Squibb & Sons, L.L.C.
$195
Gilead Sciences, Inc.
$185
Adaptive Biotechnologies Corporation
$179
Lilly USA, LLC
$160
Pharmacosmos Therapeutics Inc.
$151
Medtronic, Inc.
$142
SOBI, INC
$141
Janssen Scientific Affairs, LLC
$137
Rigel Pharmaceuticals, Inc.
$123
Genentech USA, Inc.
$119
TAIHO ONCOLOGY, INC.
$114
Regeneron Healthcare Solutions, Inc.
$112
Bayer Healthcare Pharmaceuticals Inc.
$107
Merck Sharp & Dohme LLC
$103
Takeda Pharmaceuticals U.S.A., Inc.
$92
Eisai Inc.
$88
PharmaEssentia USA Corporation
$82
Octapharma USA, Inc.
$78
Stemline Therapeutics Inc.
$74
CSL Behring
$66
GENZYME CORPORATION
$65
ARRAY BIOPHARMA INC
$62
Kite Pharma, Inc.
$56
GlaxoSmithKline, LLC.
$55
Menarini Silicon Biosystems, Inc.
$55
Exelixis Inc.
$55
Mirati Therapeutics, Inc.
$53
JAZZ PHARMACEUTICALS INC.
$51
BeiGene USA, Inc.
$49
Celgene Corporation
$46
Deciphera Pharmaceuticals Inc.
$46
SERVIER PHARMACEUTICALS LLC
$39
Astellas Pharma US Inc
$39
ARGENX US, INC.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
TerSera Therapeutics LLC
$25
ABBVIE INC.
$23
Daiichi Sankyo Inc.
$20
ADC Therapeutics America, Inc.
$19
Alexion Pharmaceuticals, Inc.
$18
Amgen Inc.
$14
ADMA BioManufacturing LLC
$14
Top 3 companies account for 22.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,719
Novartis Pharmaceuticals Corporation
$1,723
Rigel Pharmaceuticals, Inc.
$1,405
Amgen Inc.
$1,264
E.R. Squibb & Sons, L.L.C.
$1,221
PFIZER INC.
$1,151
AstraZeneca Pharmaceuticals LP
$990
Janssen Biotech, Inc.
$660
GENZYME CORPORATION
$640
Genentech USA, Inc.
$629
Seagen Inc.
$597
Takeda Pharmaceuticals U.S.A., Inc.
$594
Incyte Corporation
$578
Merck Sharp & Dohme LLC
$563
Celgene Corporation
$541
Astellas Pharma US Inc
$465
Exelixis Inc.
$390
Gilead Sciences, Inc.
$331
Regeneron Healthcare Solutions, Inc.
$326
Alexion Pharmaceuticals, Inc.
$310
Eisai Inc.
$307
Kite Pharma, Inc.
$284
GlaxoSmithKline, LLC.
$276
Daiichi Sankyo Inc.
$249
Pharmacyclics LLC, An AbbVie Company
$245
Lilly USA, LLC
$240
Taiho Oncology, Inc.
$234
Merck Sharp & Dohme Corporation
$218
Janssen Scientific Affairs, LLC
$214
Pharmacosmos Therapeutics Inc.
$199
Mirati Therapeutics, Inc.
$195
Bayer HealthCare Pharmaceuticals Inc.
$194
NOVARTIS PHARMACEUTICALS CORPORATION
$183
Adaptive Biotechnologies Corporation
$179
G1 Therapeutics, Inc.
$168
Puma Biotechnology, Inc.
$161
Octapharma USA, Inc.
$157
Bayer Healthcare Pharmaceuticals Inc.
$152
Medtronic, Inc.
$142
SOBI, INC
$141
TAIHO ONCOLOGY, INC.
$132
TESARO, Inc.
$131
Karyopharm Therapeutics Inc.
$131
SERVIER PHARMACEUTICALS LLC
$130
Janssen Pharmaceuticals, Inc
$128
Stemline Therapeutics Inc.
$120
PharmaEssentia USA Corporation
$118
EISAI INC.
$113
ABBVIE INC.
$113
Seattle Genetics, Inc.
$110
AbbVie Inc.
$101
CSL Behring
$99
BOSTON SCIENTIFIC CORPORATION
$95
TerSera Therapeutics LLC
$95
ARRAY BIOPHARMA INC
$86
BeiGene USA, Inc.
$86
JAZZ PHARMACEUTICALS INC.
$84
AMAG Pharmaceuticals, Inc.
$65
Deciphera Pharmaceuticals Inc.
$65
Ipsen Biopharmaceuticals, Inc
$62
MorphoSys, US Inc.
$55
Menarini Silicon Biosystems, Inc.
$55
CTI BioPharma Corp.
$43
Acrotech Biopharma LLC
$40
ADMA BioManufacturing LLC
$39
Kyowa Kirin, Inc.
$38
Teva Pharmaceuticals USA, Inc.
$38
ARGENX US, INC.
$35
Jazz Pharmaceuticals Inc.
$35
TOLMAR Pharmaceuticals, Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$34
ADC Therapeutics America, Inc.
$33
Coherus Biosciences Inc.
$33
SANOFI-AVENTIS U.S. LLC
$25
Servier Pharmaceuticals LLC
$22
Dova Pharmaceuticals
$21
Sunovion Pharmaceuticals Inc.
$20
EMD Serono, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
Myriad Genetic Laboratories, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
EUSA Pharma (US) LLC
$15
PORTOLA PHARMACEUTICALS, LLC
$15
MEDIVATION FIELD SOLUTIONS LLC
$14
Global Blood Therapeutics, Inc.
$14
Clovis Oncology, Inc.
$13
Secura Bio, Inc.
$10
Top 3 companies account for 24.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ANDEXXA · AUGTYRO · Alecensa · Aliqopa · Aranesp · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · Cabometyx · Cellsearch · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · EVENITY · EXKIVITY · Enhertu · Erleada · FERAHEME · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GENERAL PAIN MANAGEMENT · GILOTRIF · Halaven · Herceptin · Hizentra · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PRADAXA · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · RYDAPT · RYLAZE · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIGNIA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · Utibron · VENCLEXTA · VERZENIO · VONJO · VYVGART HYTRULO · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Medical oncologists within 10 mi
1
Per 100K population
1.2
County median income
$68,546
Nearest hospital
SOUTHEAST GEORGIA HEALTH SYSTEM- BRUNSWICK CAMPUS
10.1 mi
10.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Moran is a mixed practice specialist, with above-average Medicare volume (top 16% in GA), with low-engagement industry engagement in the top 20% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Moran experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Moran performed 13,260 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moran receive payments from pharmaceutical companies?
Yes. Dr. Moran received a total of $24,049 from 87 companies across 954 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moran's costs compare to other medical oncologists in Brunswick?
Dr. Moran's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Brunswick
Browse medical oncologists in Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in GA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in GA
Which GA medical oncologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology